Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BIOPHARMA AS
AS
Active
Org 981712315
Vallehellene 4, 1664
Rolvsøy
Manufacture of homogenised food preparations and dietetic food
· NACE 1086
Est. 2000
8 employees
Watchlist
Share
Norway
/
Companies
/
Manufacture of homogenised food preparations and dietetic food
/
BIOPHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
9M
18M
27M
36M
31M
2020
26M
2021
27M
2022
24M
2023
28M
2024
EBITDA
NOK millions
0M
2M
3M
5M
7M
5M
2020
4M
2021
1M
2022
4M
2023
6M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
31 449
26 131
26 984
24 069
28 278
Staff expenses
−7 221
−6 716
−5 771
−5 238
−5 240
EBITDA
4 678
3 657
732
3 580
5 631
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
4 678
3 657
732
3 580
5 631
Net financials
32
24
141
169
490
Profit before tax
4 711
3 681
873
3 749
6 121
Tax
1 034
810
192
824
1 352
Net profit
3 677
2 871
681
2 925
4 769
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
11 203
15 149
16 293
11 249
18 021
Equity
1 572
1 443
2 658
5 582
5 851
Long-term debt
2 137
1 710
1 368
1 094
875
Short-term debt
7 494
11 997
12 268
4 572
11 294
Total debt
9 631
13 706
13 636
5 666
12 170
Financial ratios
5-year trend
EBITDA margin
19.9%
This company
15.8%
Market median
+26% vs market
2020
2024
Equity ratio
32.5%
This company
38.2%
Market median
+15% vs market
2020
2024
Return on equity
81.5%
This company
18.4%
Market median
+343% vs market
2020
2024
Net profit margin
16.9%
This company
8.1%
Market median
+109% vs market
2020
2024
Asset turnover
1.57×
This company
1.12×
Market median
+40% vs market
2020
2024
Debt / equity
2.08×
This company
0.62×
Market median
-235% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on BIOPHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
